Edges in Network
Network | GSE16391_egf1520 - GSE16391 - SiGN-BN HC+Bootstrap |
Network Description | GGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial |
Node | CYP1A2 |
Upstream (Parents) |
---|
(<<) ARID3B → CYP1A2 |
(<<) CEND1 → CYP1A2 |
(<<) E2F4 → CYP1A2 |
(<<) EXOC3L2 → CYP1A2 |
(<<) LOC100131581 → CYP1A2 |
(<<) LRCH4 → CYP1A2 |
(<<) MAP2K5 → CYP1A2 |
(<<) MYH14 → CYP1A2 |
(<<) PDE4C → CYP1A2 |
(<<) POLR1B → CYP1A2 |
(<<) PROCR → CYP1A2 |
(<<) RHOQ → CYP1A2 |
(<<) SERPINB1 → CYP1A2 |
(<<) ST3GAL6 → CYP1A2 |
(<<) T → CYP1A2 |
(<<) WBP4 → CYP1A2 |
(<<) WNT6 → CYP1A2 |
Downstream (Children) |
---|
CYP1A2 → CASP7 (>>) |
CYP1A2 → CCND3 (>>) |
CYP1A2 → GPR150 (>>) |
CYP1A2 → IL1F9 (>>) |
CYP1A2 → INE1 (>>) |
CYP1A2 → KREMEN2 (>>) |
CYP1A2 → MAPK12 (>>) |
CYP1A2 → MMP15 (>>) |
CYP1A2 → MYL6B (>>) |
CYP1A2 → RPL35A (>>) |
CYP1A2 → SNX22 (>>) |
CYP1A2 → SOX9 (>>) |
CYP1A2 → TMEM154 (>>) |
CYP1A2 → VANGL1 (>>) |